Literature DB >> 19822141

Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population.

Elizabeth Suchi Chen1, Diego Robles Mazzotti, Tatiane Katsue Furuya, Maysa Seabra Cendoroglo, Luiz Roberto Ramos, Lara Quirino Araujo, Rommel Rodriguez Burbano, Marília de Arruda Cardoso Smith.   

Abstract

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a nuclear transcription factor strictly involved in lipid and lipoprotein metabolisms. Thus, PPARalpha gene polymorphisms have been investigated as cardiovascular risk factors. We aimed to investigate associations of L162V and intron 7G>C polymorphisms with common morbidities affecting a Brazilian elderly cohort as well as with lipid and protein serum levels. Genotyping was performed by polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP), and allele frequencies were determined. In addition, we performed the linkage disequilibrium analysis. Descriptive statistics, logistic regression analysis, and Student's t-test were used. Rare alleles for L162V and intron 7 G>C polymorphisms showed frequencies of 0.047 and 0.199, respectively. Our data showed that these polymorphisms were in linkage disequilibrium (p=0.0002). Intron 7 G>C polymorphism presented a tendency of association with neoplasia (p=0.053), and C allele was associated with higher HDL (p=0.010), lower triglycerides (p=0.001), and VLDL levels (p=0.003) compared to G allele. These data might suggest a protective role of intron 7 G>C polymorphism in the development of cardiovascular diseases and will help to clarify the importance of PPARalpha polymorphisms as key modulators of lipid metabolism in Brazilian population. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822141     DOI: 10.1016/j.yexmp.2009.10.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  9 in total

1.  PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population.

Authors:  Luciana O Lima; Silvana Almeida; Mara H Hutz; Marilu Fiegenbaum
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

2.  APOA1/A5 variants and haplotypes as a risk factor for obesity and better lipid profiles in a Brazilian Elderly Cohort.

Authors:  Elizabeth Suchi Chen; Tatiane Katsue Furuya; Diego Robles Mazzotti; Vanessa Kiyomi Ota; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Lipids       Date:  2010-05-18       Impact factor: 1.880

Review 3.  PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.

Authors:  Alejandra V Contreras; Nimbe Torres; Armando R Tovar
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 4.  Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome.

Authors:  Chen Dong; Hui Zhou; Chong Shen; Lu-Gang Yu; Yi Ding; Yong-Hong Zhang; Zhi-Rong Guo
Journal:  World J Diabetes       Date:  2015-05-15

5.  Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population.

Authors:  Bo Hai; Huijian Xie; Zhirong Guo; Chen Dong; Ming Wu; Qiu Chen; Zhengyuan Zhou; Qiurong Zhu; Mengmeng Liu; Wei Fan; Hui Zhou
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

Review 6.  Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.

Authors:  C S Paththinige; N D Sirisena; Vhw Dissanayake
Journal:  Lipids Health Dis       Date:  2017-06-02       Impact factor: 3.876

Review 7.  Impact of PPAR-Alpha Polymorphisms-The Case of Metabolic Disorders and Atherosclerosis.

Authors:  Massimiliano Ruscica; Marco Busnelli; Enrico Runfola; Alberto Corsini; Cesare R Sirtori
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

8.  PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Lipids Health Dis       Date:  2014-01-26       Impact factor: 3.876

9.  Effects of Eicosapentaenoic Acid Supplementation on Lipid and Lipoprotein Profile in Hypertriglyceridemic Subjects with Different Proliferator-activated Receptor Alpha Genotypes.

Authors:  Hamideh Pishva; Parvin Mehdipour; Mohammad Reza Eshraghian; Soltan-Ali Mahboob
Journal:  Int J Prev Med       Date:  2014-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.